BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/20/2017 4:40:00 PM | Browse: 1143 | Download: 1879
 |
Received |
|
2016-06-21 09:58 |
 |
Peer-Review Started |
|
2016-06-24 17:45 |
 |
To Make the First Decision |
|
2016-08-05 15:21 |
 |
Return for Revision |
|
2016-08-11 15:30 |
 |
Revised |
|
2016-08-30 03:45 |
 |
Second Decision |
|
2016-10-14 14:23 |
 |
Accepted by Journal Editor-in-Chief |
|
2016-10-14 23:59 |
 |
Accepted by Executive Editor-in-Chief |
|
2016-10-27 17:29 |
 |
Articles in Press |
|
2016-10-27 17:29 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2017-01-12 17:24 |
 |
Publish the Manuscript Online |
|
2017-01-20 16:40 |
ISSN |
2150-5349 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Basic Study |
Article Title |
Plecanatide-mediated activation of guanylate cyclase-C suppresses inflammation-induced colorectal carcinogenesis in Apc+/Min-FCCC mice
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Wen-Chi L Chang, Shet Masih, Anusha Thadi, Viren Patwa, Apoorva Joshi, Harry S Cooper, Vaseem A Palejwala, Margie L Clapper and Kunwar Shailubhai |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
National Cancer Institute |
CA 133689 |
National Cancer Institute |
CA 006927 |
|
Corresponding Author |
Kunwar Shailubhai, Doctor of Philosophy, Chief Scientific Officer, R and D Center, Synergy Pharmaceuticals Inc., 3805 Old Easton Road, Doylestown, PA 18902, United States. shailu@synergypharma.com
|
Key Words |
Guanylate cyclase-C; Uroguanylin; Plecanatide; Inflammation; Colorectal cancer |
Core Tip |
Plecanatide, an analog of human uroguanylin, binds and activates guanylate cyclase-C signaling to produce its anti-tumorigenic activity. This study provides the first evidence that oral treatment with plecanatide inhibits inflammation-driven colorectal carcinogenesis. The potential mechanism in Apc+/Min?FCCC mice appears to be agonist-mediated activation of guanylate cyclase-C signaling, resulting in inhibition of Wnt/b-catenin pathway and downregulation of pro-inflammatory cytokines and growth factors.
|
Publish Date |
2017-01-20 16:40 |
Citation |
Chang WCL, Masih S, Thadi S, Patwa V, Joshi A, Cooper HS, Palejwala VA, Clapper ML, Shailubhai K. Plecanatide-mediated activation of guanylate cyclase-C suppresses inflammation-induced colorectal carcinogenesis in Apc+/Min-FCCC mice. World J Gastrointest Pharmacol Ther 2017; 8(1): 47-59 |
URL |
http://www.wjgnet.com/2150-5349/full/v8/i1/47.htm |
DOI |
http://dx.doi.org/10.4292/wjgpt.v8.i1.47 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345